Physician profile
Robert D Kelly
NPI 1174708267
$6,658.03
in general payments reported to CMS, 2019-2025
18 companies · $651 in 2025
The $651 reported for 2025 was more than what 83% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2020: $511 · 2021: $1,029 · 2022: $1,372 · 2023: $1,356 · 2024: $1,204 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,724 · Travel and Lodging: $487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,723.97 |
| Travel and Lodging | $486.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,333.18 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, Intracept |
| Vertos Medical, INC. | $1,364.75 | 2019-2024 | Mild Device Kit |
| Abbvie INC. | $505.29 | 2021-2025 | |
| Globus Medical, INC. | $376.01 | 2022-2023 | Affirm |
| Saluda Medical Americas, INC. | $287.81 | 2024-2025 | Evoke |
| Relievant Medsystems, INC. | $132.48 | 2022-2023 | Intracept |
| Allergan, INC. | $114.81 | 2020-2022 | |
| Stryker Corporation | $109.09 | 2024 | Mild Device Kit |
| Foundation Fusion Solutions, LLC | $88.20 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $83.23 | 2019-2024 | Xtampza, Belbuca |
| Abbott Laboratories | $58.93 | 2022 | |
| Painteq LLC | $58.33 | 2024 | Painteq |
| Spr Therapeutics, INC | $45.39 | 2022-2023 | Sprint Pns System |
| Abiomed | $23.39 | 2024 | Impella |
| Curonix LLC | $22.43 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $20.07 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.27 | 2025 | Relistor |
| Siemens Medical Solutions USA, INC. | $16.37 | 2023 | Cios Select |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.